BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 11798681)

  • 1. [The role of nitric oxide on the functional change of interleukin-1 beta and interleukin-6 induced rat pancreatic islets of Langerhans].
    Chen H; Cai D; Wang M; Liu H
    Zhonghua Nei Ke Za Zhi; 1999 Jul; 38(7):458-61. PubMed ID: 11798681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S-methyl-L-thiocitrulline counteracts interleukin 1 beta induced suppression of pancreatic islet function in vitro, but does not protect against multiple low-dose streptozotocin-induced diabetes in vivo.
    Sternesjö J; Welsh N; Sandler S
    Cytokine; 1997 May; 9(5):352-9. PubMed ID: 9195135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of nitric oxide in IL-1 beta-mediated dysfunction of rodent islets of Langerhans. Implications for the function of intrahepatic islet grafts.
    Xenos ES; Stevens RB; Sutherland DE; Lokeh A; Ansite JD; Casanova D; Gores PF; Platt JL
    Transplantation; 1994 Apr; 57(8):1208-12. PubMed ID: 8178348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokines suppress human islet function irrespective of their effects on nitric oxide generation.
    Eizirik DL; Sandler S; Welsh N; Cetkovic-Cvrlje M; Nieman A; Geller DA; Pipeleers DG; Bendtzen K; Hellerström C
    J Clin Invest; 1994 May; 93(5):1968-74. PubMed ID: 7514190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppressive effects of a selective inducible nitric oxide synthase (iNOS) inhibitor on pancreatic beta-cell dysfunction.
    Kato Y; Miura Y; Yamamoto N; Ozaki N; Oiso Y
    Diabetologia; 2003 Sep; 46(9):1228-33. PubMed ID: 12898012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitric oxide and cyclic GMP formation induced by interleukin 1 beta in islets of Langerhans. Evidence for an effector role of nitric oxide in islet dysfunction.
    Corbett JA; Wang JL; Hughes JH; Wolf BA; Sweetland MA; Lancaster JR; McDaniel ML
    Biochem J; 1992 Oct; 287 ( Pt 1)(Pt 1):229-35. PubMed ID: 1384465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-1 beta-induced nitric oxide production in isolated rat pancreatic islets requires gene transcription and may lead to inhibition of the Krebs cycle enzyme aconitase.
    Welsh N; Eizirik DL; Bendtzen K; Sandler S
    Endocrinology; 1991 Dec; 129(6):3167-73. PubMed ID: 1720090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human pancreatic islet beta-cell destruction by cytokines involves oxygen free radicals and aldehyde production.
    Rabinovitch A; Suarez-Pinzon WL; Strynadka K; Lakey JR; Rajotte RV
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3197-202. PubMed ID: 8784069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The stimulatory effect of IL-1beta on the insulin secretion of rat pancreatic islet is not related with iNOS pathway.
    Jeong IK; Oh SH; Chung JH; Min YK; Lee MS; Lee MK; Kim KW
    Exp Mol Med; 2002 Mar; 34(1):12-7. PubMed ID: 11989973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of interferon regulatory factor-1 in cytokine-induced mRNA expression and cell death in murine pancreatic beta-cells.
    Pavlovic D; Chen MC; Gysemans CA; Mathieu C; Eizirik DL
    Eur Cytokine Netw; 1999 Sep; 10(3):403-12. PubMed ID: 10477397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric oxide mediates IL-1 beta-induced islet dysfunction and destruction: prevention by dexamethasone.
    Corbett JA; Wang JL; Misko TP; Zhao W; Hickey WF; McDaniel ML
    Autoimmunity; 1993; 15(2):145-53. PubMed ID: 7692996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human pancreatic islet beta-cell destruction by cytokines is independent of nitric oxide production.
    Rabinovitch A; Suarez-Pinzon WL; Strynadka K; Schulz R; Lakey JR; Warnock GL; Rajotte RV
    J Clin Endocrinol Metab; 1994 Oct; 79(4):1058-62. PubMed ID: 7962274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin 1 beta induces the formation of nitric oxide by beta-cells purified from rodent islets of Langerhans. Evidence for the beta-cell as a source and site of action of nitric oxide.
    Corbett JA; Wang JL; Sweetland MA; Lancaster JR; McDaniel ML
    J Clin Invest; 1992 Dec; 90(6):2384-91. PubMed ID: 1334975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Irreversible inhibition of metabolic function and islet destruction after a 36-hour exposure to interleukin-1beta.
    Scarim AL; Heitmeier MR; Corbett JA
    Endocrinology; 1997 Dec; 138(12):5301-7. PubMed ID: 9389514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 1-hour pulse with IL-1 beta induces formation of nitric oxide and inhibits insulin secretion by rat islets of Langerhans: evidence for a tyrosine kinase signaling mechanism.
    Corbett JA; Sweetland MA; Lancaster JR; McDaniel ML
    FASEB J; 1993 Feb; 7(2):369-74. PubMed ID: 8440413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of interleukin 1-induced apoptosis in rat islets using in situ specific labelling of fragmented DNA.
    Dunger A; Augstein P; Schmidt S; Fischer U
    J Autoimmun; 1996 Jun; 9(3):309-13. PubMed ID: 8816965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epiandrosterone and dehydroepiandrosterone affect glucose oxidation and interleukin-1 beta effects in pancreatic islets.
    Laychock SG; Bauer AL
    Endocrinology; 1996 Aug; 137(8):3375-85. PubMed ID: 8754764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin 4 impairs rat pancreatic islet function in vitro by an action different to that of interleukin 1.
    Sandler S; Sternesjö J
    Cytokine; 1995 Apr; 7(3):296-300. PubMed ID: 7640349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversibility of interleukin-1 beta-induced islet destruction and dysfunction by the inhibition of nitric oxide synthase.
    Corbett JA; McDaniel ML
    Biochem J; 1994 May; 299 ( Pt 3)(Pt 3):719-24. PubMed ID: 7514870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-1 beta inhibits proinsulin conversion in rat beta-cells via a nitric oxide-dependent pathway.
    Zambre Y; Van Schravendijk C; Ling Z
    Horm Metab Res; 2001 Nov; 33(11):639-44. PubMed ID: 11733865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.